
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Mizuna (Brassica rapa var. nipposinica) contains glucosinolates that convert to isothiocyanates, activating the Nrf2 pathway to induce Phase II detoxification enzymes like NQO1 and HO-1. These compounds demonstrate 40-60% NF-κB inhibition in vitro and significant antioxidant activity with DPPH EC50 values of 20-50 μg/mL.

Reported Benefits (Provisional)
Origin & History

Mizuna (Brassica rapa var. japonica) is a cold-tolerant, fast-growing leafy green native to Japan and East Asia. A staple in Japanese cuisine, it thrives in temperate climates and is prized for its feathery leaves and mildly peppery flavor. This nutrient-dense Brassica is valued for its robust nutritional profile, offering significant antioxidant and digestive-supporting benefits.
Research Narrative (Provisional)
Scientific studies support Mizuna's role in glucosinolate-mediated detoxification, as well as its benefits for cardiovascular, immune, and digestive health. Research highlights its rich profile of antioxidants and anti-inflammatory compounds. While widely consumed, further targeted human clinical trials could provide more specific insights into optimal dosages and long-term health outcomes.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: Vitamin A, Vitamin C, Vitamin K, Folate - Minerals: Calcium, Magnesium, Potassium, Phosphorus - Macronutrients: Dietary Fiber (prebiotic) - Phytochemicals: Glucosinolates (liver detoxification, cellular protection), Flavonoids, Polyphenols, Carotenoids (antioxidant, anti-inflammatory), Chlorophyll
Reported Mechanism (Provisional)
Glucosinolates in mizuna (45.2 μmol/100g total) hydrolyze to isothiocyanates like 3-butenyl ITC and sulforaphane, which activate the Nrf2 pathway leading to upregulation of antioxidant enzymes HO-1 and NQO1. These compounds inhibit Phase I enzymes (CYP1A) while inducing Phase II detoxification enzymes, reducing carcinogen activation by 40-60% through NF-κB pathway suppression. Flavonoids like kaempferol and quercetin glycosides (10-30 mg/100g) modulate PI3K/Akt signaling for anti-inflammatory effects.
Clinical Narrative (Provisional)
Human clinical evidence for mizuna is limited to small trials. A 12-week RCT (n=30) found 200g/day mizuna increased plasma lutein by 28% and reduced LDL oxidation by 15%. A crossover study (n=20) showed 100g/day mizuna juice elevated urinary isothiocyanate metabolites 3.2-fold and improved glutathione S-transferase activity by 22%. Meta-analyses suggest Brassica vegetables may reduce colorectal cancer risk by 15-20% at ≥100g/day intake, though mizuna-specific large-scale trials are lacking.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







